Compare BODI & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BODI | PRPO |
|---|---|---|
| Founded | 1998 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.8M | 42.0M |
| IPO Year | 2020 | 2000 |
| Metric | BODI | PRPO |
|---|---|---|
| Price | $5.75 | $27.40 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | 67.1K | ★ 131.5K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 96.10 | 92.15 |
| EPS | ★ 0.47 | N/A |
| Revenue | ★ $251,727,000.00 | $24,049,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $20.48 | N/A |
| P/E Ratio | $12.47 | ★ N/A |
| Revenue Growth | N/A | ★ 29.77 |
| 52 Week Low | $4.05 | $16.01 |
| 52 Week High | $16.87 | $33.63 |
| Indicator | BODI | PRPO |
|---|---|---|
| Relative Strength Index (RSI) | 31.09 | 51.57 |
| Support Level | N/A | $25.95 |
| Resistance Level | $11.01 | $29.20 |
| Average True Range (ATR) | 0.37 | 2.27 |
| MACD | 0.05 | -0.18 |
| Stochastic Oscillator | 22.94 | 40.06 |
The Beachbody Co Inc is a fitness and nutrition company providing fitness, nutrition, and stress-reducing programs to its customers. a results-oriented company at the intersection of wellness, technology, and media. The company developed one of the original fitness digital streaming platforms with an extensive library of content containing streaming programs and streaming videos. Company products include Digital Subscriptions, Nutritional Products, and Connected Fitness Products, where the majority of revenue is from Digital Subscriptions. The Company has one operating and reporting segment. Geographically operates in the USA and the rest of the world, with maximum revenue from the United States.
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.